The Cxbladder Monitoring Study

Status:	Recruiting
Conditions:	Prostate Cancer
Therapuetic Areas:	Oncology
Healthy:	No
Age Range:	18 - Any
Updated:	4/21/2016
Start Date:	November 2012
End Date:	December 2016
Contact:	Paul J O'Sullivan, PhD
Email:	paul.osullivan@pacificedge.co.nz
Phone:	+64 3 479 5805

A Clinical, Non-intervention Study of the Cxbladder Urine Test for the Detection of Recurrent Urothelial Carcinoma (UC)

The aim of this trial is to determine the performance characteristics of the Cxbladder test
for the detection of recurrent urothelial carcinoma (UC) in patients with a recent history
of urinary tract UC, who have been treated according to standard practice and are undergoing
routine investigative cystoscopy.

The gold standard for determination of clinical truth is cystoscopy, plus any follow up
investigations relating to the current visit.

Inclusion Criteria:

- Confirmed positive diagnosis for primary or recurrent urinary tract UC over the past
2 years.

- Patient is undergoing investigative cystoscopies for the monitoring of recurrence of
UC at intervals prescribed by a clinical practitioner

- Patient is 18 years of age or older.

Exclusion Criteria:

- Prior genitourinary manipulation (cystoscopy / catheterisation / dilation) in the 14
days before urine collection, current urinary tract infection, current or known
history of urinary tract inflammatory disorder, recent history of glomerulonephritis,
nephrosis or other renal inflammatory disorders, recent history of pyelonephritis

- Patient has undergone total bladder cystectomy as treatment for bladder UC

We found this trial at

sites

U.T. Southwestern Medical Center

2201 Inwood Rd
Dallas, Texas 75235

(214) 645-8300